期刊文献+

血尿酸水平与帕金森病风险及临床特征关系的观察 被引量:2

Observation on the relationship between serum uric acid level and the risk and clinical characteristics of Parkinson's disease
下载PDF
导出
摘要 目的探讨血尿酸水平与帕金森病风险及临床特征的相关性。方法回顾性分析青岛市市立医院神经内科2016年9月至2018年3月收治的170例原发性帕金森病患者(观察组)的病例资料,选择同期性别、年龄相匹配的170例健康体检者为对照组,比较两组的血尿酸水平,并分析血尿酸水平与帕金森病患者临床特征的相关性。结果观察组血尿酸水平明显低于对照组,差异有显著性(P<0.05)。观察组与对照组组内男性血尿酸水平均高于女性,差异有显著性(P<0.05)。112例Hoehn-Yahr分期早期患者血尿酸水平明显高于58例Hoehn-Yahr分期中晚期患者,差异有显著性(P=0.043)。Pearson相关分析显示,帕金森病患者血尿酸水平与其病程长短、年龄、起病年龄均无相关性(r=-0.031、-0.031、-0.138,P=0.692、0.688、0.075)。结论尿酸为帕金森病的独立保护因素。 Objective To explore the correlation between blood uric acid level and Parkinson’s disease risk and clinical characteristics.Method The case data of 170 patients with primary Parkinson’s disease(observation group) admitted to the department of neurology of Qingdao municipal hospital from September 2016 to March 2018 were retrospectively analyzed, and 170 healthy subjects with matching sex and age were selected as the control group.Blood uric acid levels were compared between the two groups,and the correlation between serum uric acid level and clinical characteristics of Parkinson’s disease was analyzed. Result The blood uric acid level in the observation group was lower than that in the control group, and the difference was signi? cant(P<0.05).There are differences between the sexes in both group(P<0.05). There was statistically signi? cant in the blood uric acid level between the early group and the middle-late group(P =0.043). There was no signi? cant correlation between serum uric acid level and duration, age and age of onset of Parkinson’s disease(r=-0.031、-0.031、-0.138,P=0.692、0.688、0.075). Conclusion Uric acid is an independent protective factor for Parkinson’s disease.
作者 王蒙蒙 李慧超 邢成名 李冬梅 WANG Meng-meng;LI Hui-chao;XING Cheng-ming;LI Dong-mei(Department of Neurology,Qingdao Municipal Hospital,Shandong Qingdao 266071,China;Department of Thyroid Surgery,Affiliated Hospital of Qingdao University,Shandong Qingdao 266003,China)
出处 《中国医刊》 CAS 2019年第3期273-275,共3页 Chinese Journal of Medicine
关键词 帕金森病 临床特征 血尿酸 Parkinson’s disease Clinical features Blood uric acid
  • 相关文献

参考文献3

二级参考文献44

  • 1陈双庆,蔡庆,沈玉英,赵中,周华.轻度认知功能损害患者扣带后回谷氨酸多体素氢质子磁共振波谱研究[J].中华诊断学电子杂志,2013,1(1). 被引量:33
  • 2姚庆和,高国栋.肌苷对帕金森病小鼠模型的神经保护作用[J].第四军医大学学报,2005,26(2):141-145. 被引量:20
  • 3Calne DB,Snow BJ,Lee C.Criteria for diagnosing Parkinson's disease.Ann Neurol,1992,32 Suppl:125-127.
  • 4Gelb GJ,Oliver E,Gilman S.Diagnostic criteria for Parkinson's disease.Arch Neurol,1999,56:33-39.
  • 5Gibb WRG.The neuropathology of Parkinson's disease.In:Jankovic J,Tolosa E,eds.Parkinson's disease and movement disorders.Baltimore:Urban and Schwarzenberg,1988.205-223.
  • 6Koller WC.How accurately can Parkinson's disease be diagnosed?Neurology,1992,42Suppl 1:6-16.
  • 7Paulson HL,Stern M.Clinical Manifestations of Parkinson's disease.In:Watts RL,Koller WC,eds.Movement disorders.New York:McGraw-Hill,2004.233-245.
  • 8Hughes AJ,Daniel SE,Kilford L,et al.Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinico-pathological study of 100 cases.J Neurol Neurosurg Psychiatry,1992,55:181-184.
  • 9The Guideline Review Panel of NICE (the national institute for clinical excellence).Diagnosis and management in primary and secondary care.In Parkinson's disease--full guideline,second consultation,2006.34-38.
  • 10Guerreiro S,Ponceau A,Toulorge D, et al. Protection of midbrain do- paminergic neurons by the end-product of purine metabolism uric acid potentiation by low-level depolarization [J]. J Neurochem, 2009, 109 (4) :1118-1128.

共引文献640

同被引文献21

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部